Revvity Inc (RVTY)
102.50
-2.52
(-2.40%)
USD |
NYSE |
Apr 30, 16:00
102.50
0.00 (0.00%)
After-Hours: 20:00
Revvity Revenue (TTM): 2.751B for Dec. 31, 2023
Revenue (TTM) Chart
Historical Revenue (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 2.751B |
September 30, 2023 | 2.796B |
June 30, 2023 | 2.837B |
March 31, 2023 | 3.024B |
December 31, 2022 | 3.312B |
September 30, 2022 | 3.599B |
June 30, 2022 | 3.748B |
March 31, 2022 | 4.081B |
December 31, 2021 | 4.425B |
September 30, 2021 | 3.633B |
June 30, 2021 | 3.735B |
March 31, 2021 | 3.319B |
December 31, 2020 | 2.663B |
September 30, 2020 | 3.234B |
June 30, 2020 | 2.977B |
March 31, 2020 | 2.887B |
December 31, 2019 | 2.884B |
September 30, 2019 | 2.835B |
June 30, 2019 | 2.802B |
March 31, 2019 | 2.783B |
December 31, 2018 | 2.778B |
September 30, 2018 | 2.663B |
June 30, 2018 | 2.543B |
March 31, 2018 | 2.387B |
December 31, 2017 | 2.257B |
Date | Value |
---|---|
September 30, 2017 | 2.182B |
June 30, 2017 | 2.142B |
March 31, 2017 | 2.132B |
December 31, 2016 | 2.116B |
September 30, 2016 | 1.999B |
June 30, 2016 | 2.048B |
March 31, 2016 | 2.076B |
December 31, 2015 | 2.105B |
September 30, 2015 | 2.095B |
June 30, 2015 | 2.074B |
March 31, 2015 | 2.066B |
December 31, 2014 | 2.070B |
September 30, 2014 | 2.221B |
June 30, 2014 | 2.201B |
March 31, 2014 | 2.185B |
December 31, 2013 | 2.160B |
September 30, 2013 | 2.131B |
June 30, 2013 | 2.119B |
March 31, 2013 | 2.100B |
December 31, 2012 | 2.105B |
September 30, 2012 | 2.082B |
June 30, 2012 | 2.025B |
March 31, 2012 | 1.982B |
December 31, 2011 | 1.919B |
September 30, 2011 | 1.847B |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (TTM) Range, Past 5 Years
2.663B
Minimum
Dec 2020
4.425B
Maximum
Dec 2021
3.239B
Average
3.024B
Median
Mar 2023
Revenue (TTM) Benchmarks
Agilent Technologies Inc | 6.735B |
Bruker Corp | 2.964B |
Azenta Inc | 641.02M |
Harvard Bioscience Inc | 112.25M |
Bionano Genomics Inc | 36.12M |